Genmab | Capitale Di Prestito



Loan Capital Cambiamento Data
Agios Pharmaceuticals USD 0 0 2025-03
Almirall EUR 390.63M 38.87M 2024-12
Amarin USD 0 0 2024-09
Amgen USD 54.01B 2.54B 2025-03
AstraZeneca USD 27.89B 154M 2025-03
Bayer EUR 35.02B 468M 2025-03
BioMarin Pharmaceutical USD 595.65M 244K 2025-03
Demant DKK 14.59B 1.4B 2024-12
Exelixis USD 0 0 2025-04
Fresenius Medical Care EUR 9.51B 253.41M 2025-03
Galapagos EUR 7.79M 453K 2025-03
Genmab DKK 129M 808M 2025-03
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
GN Store Nord DKK 8.76B 640M 2025-03
GRIFOLS EUR 9.39B 709.61M 2025-03
Hikma Pharmaceutical USD 1.06B 31M 2024-06
Insmed USD 1.13B 888K 2025-03
Lonza CHF 4.24B 602M 2024-12
Merck EUR 6.37B 1.51B 2024-12
Novartis USD 22.93B 2.41B 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.41B 1.62B 2025-03
UCB EUR 2.82B 166M 2024-12



Genmab Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.